Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
about
Small-molecule inhibitors of dengue-virus entryRelease of dengue virus genome induced by a peptide inhibitorMEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virusInhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein GcEarly Bunyavirus-Host Cell InteractionsFlaviviruses: braking the enteringFlavivirus cell entry and membrane fusionCell entry of enveloped virusesCarbohydrate-related inhibitors of dengue virus entryStructure of a Dengue Virus Envelope Protein Late-Stage Fusion IntermediateViral membrane fusion.Dengue virus ensures its fusion in late endosomes using compartment-specific lipids.Inhibition of influenza A virus infection in vitro by peptides designed in silicoDiscovery of host-targeted covalent inhibitors of dengue virusIn vitro and in vivo studies identify important features of dengue virus pr-E protein interactionsA molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in miceNovel approaches to flavivirus drug discovery.Sequential conformational rearrangements in flavivirus membrane fusion.A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses.The C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry.The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entryFusion of protegrin-1 and plectasin to MAP30 shows significant inhibition activity against dengue virus replicationT cell epitope mapping of the e-protein of West Nile virus in BALB/c mice.Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus.Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virusAnti-dengue virus serotype 2 activity and mode of action of a novel peptide.Identification of a specific region in the e1 fusion protein involved in zinc inhibition of semliki forest virus fusion.Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine.Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates.Cross-inhibition of chikungunya virus fusion and infection by alphavirus E1 domain III proteins.A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses.Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases.Mutational analysis of the zippering reaction during flavivirus membrane fusion.A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.Infectivity inhibition by overlapping synthetic peptides derived from the gH/gL heterodimer of herpes simplex virus type 1.Peptide inhibitors against dengue virus infection.A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo.The membrane-proximal "stem" region increases the stability of the flavivirus E protein postfusion trimer and modulates its structureChemoproteomic profiling identifies changes in DNA-PK as markers of early dengue virus infection.5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses
P2860
Q22583513-C1B59CCF-AF4F-4A9B-A50D-5CC25D78B98AQ26248897-F12556DC-D77F-499E-A34A-37724271D0EDQ26700001-8D4CE30F-F06D-456B-A472-AADA4284731AQ26700097-B41D5927-1484-4CB1-817F-EF3696128BF9Q26746919-51C2B50E-7A78-4C39-B108-ACF6A9512296Q26852435-12D93681-B637-44C6-8BA8-7198460D339DQ26852458-104291D2-AF6B-44D7-A470-1A77FE298FD7Q26863682-E22A33B0-E9C8-46E3-9EDC-8C2C6059BD6BQ26864413-5858B616-8B06-47F8-8C98-4184FAC785B6Q27675461-F85EF659-077C-4E72-ABF3-6C91644CD671Q28080422-07CF1C3C-F85E-4A27-8859-4E8DBDEC0179Q28475709-10C36C92-FF8D-4FE8-85F1-B41216862C91Q28534343-F1438951-44F8-409D-889E-D91386DD2AB8Q28733542-77BD5C9F-F73E-40A6-ACD4-3C3DFCB67A9FQ33727990-EDC0EE2D-50F4-4D39-99EA-0A514EA29282Q33982616-3A697DE7-E422-497B-AD07-FC9C8516D81CQ34206832-3AB38A10-80DA-49C7-A600-316BA9BD2301Q34948281-75F95ED1-4011-4E6B-8B8F-06E079A21C20Q34999859-C2DD7F74-8B73-481C-B200-0914D5C0654CQ35000217-2D9FBCDD-9A41-4007-9DF1-C2E0D4DDD8B9Q35076656-1668F04A-D29B-4A75-94CF-218FCCB95022Q35145487-A32E50B6-446F-4580-8887-2BC7CFE937E2Q35519408-89430BF5-809C-40BC-BACB-0ECAE7C44CF1Q35604856-28619888-A925-403B-9861-7792B7213088Q35641434-F29D0627-CD6C-4942-840E-BB01F9C51790Q35739141-55C3FF9C-1AC8-4037-AC87-CF3E6670292EQ35826908-87662AA0-ACBB-46A6-85D7-59F9884C5BA2Q35860797-F8869B2F-302A-46D5-A204-9CD1F402B66CQ36626209-485F3CD6-B2AD-426D-829F-3349377148B6Q36978892-BEB91C6E-3AE1-483D-9254-491BCE5F777AQ38157419-B3574DC3-3E30-4AD6-8B31-597AE4B3B175Q38261556-F5F20B0D-E76E-4290-927F-A91A3FC56BAAQ38286210-F511B154-162A-4979-B735-2E933C571BC9Q38884987-73A13A95-3D37-4828-8DB6-B83368936F37Q38962811-B1563811-A432-4F3A-A53C-9988495657B3Q39017020-1BFFF962-BF95-4015-92F3-58D1467F779FQ39051535-5213B7C0-5754-4DA0-92A5-2459A8E45D53Q39134378-6096C100-48EF-491F-BC7A-54CAB8DFD404Q39274197-7FE301CB-0945-472B-AF37-5DC457138F3DQ39788993-5FF787AE-5533-4697-8041-392C1DB53846
P2860
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
description
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2010/04/08)
@fr
articolo scientifico (pubblicato il 2010/04/08)
@it
artigo científico (publicado na 2010/04/08)
@pt
artículu científicu espublizáu en 2010
@ast
im April 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 8 April 2010)
@en
vedecký článok (publikovaný 2010/04/08)
@sk
videnskabelig artikel (udgivet 2010/04/08)
@da
name
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@ast
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@en
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@nl
type
label
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@ast
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@en
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@nl
prefLabel
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@ast
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@en
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@nl
P2093
P2860
P3181
P1433
P1476
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
@en
P2093
Aaron G Schmidt
Priscilla L Yang
Stephen C Harrison
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1000851
P577
2010-04-08T00:00:00Z